Skip to main content

Table 2 Component loadings

From: Application of principal component analysis and logistic regression model in lupus nephritis patients with clinical hypothyroidism

 PC1PC2PC3PC4PC5PC6PC7PC8PC9
WBC.020−.023.469.094−.006.035−.021−.041.084
HB−.067.206.080.018−.024−.097.070.179.118
PLT−.002.105.004−.009.129−.237−.075.261.054
N.032−.041.471.064.009.023.007−.109.052
L−.092−.053−.009.017−.017.121−.058.405.042
TP.063.366−.022.067−.028.128−.017−.008−.015
ALB.064.405−.058−.077−.122.013.007−.048.001
GLB.031.143.026.182.083.182−.033.037−.023
Scr.347.092−.029−.108.019.039−.009−.079−.137
BUN.299.055.052−.142.033.021−.011−.074.069
UA.311.068.084.028.028.071.027.004−.002
TG.203.060.006.138−.109−.015.080.068−.005
TC.159.097−.114−.076−.054−.012.030.442−.152
HDL−.021−.023.057−.315.084.178.042.185−.152
LDL.080.135.021.000−.140−.273.354−.167.245
HDLTC−.147−.021.102−.234−.009.225.014−.103−.045
ESR−.028−.047−.010.128.339−.115−.063.119−.036
CRP.051−.035.056−.104.442−.114.114−.242−.157
C3.060.257−.029−.107.063−.141−.008.040−.174
C4−.035−.021−.011.108.060−.429−.027−.118.017
IgG.057.107.012.104−.014.289−.052−.010−.019
IgA−.021−.099−.013−.186.461.020.008.025.151
IgM−.109−.099.130.459−.100.080.031−.025−.195
Anti-dsDNA antibodies−.023−.056−.081−.121.138.016−.090.163.289
Anti-Sm antibodies.035.004−.010−.059.004.028.488−.039−.078
Anti-SSA antibodies.016−.010.001−.060−.018.038−.006.088.147
Anti-SSB antibodies−.010.013−.037−.018−.051−.053.061−.062−.057
Anti-U1RNP antibodies−.023−.037.000−.021.057−.008.444−.027−.045
Anti-RNP antibodies−.020.003.093−.057−.035−.036.000−.051.579
  1. Loading pattern of the thirty clinical values on the nine main principal components. The loadings of the variables most relevant for the component interpretation are bolded